9999999995-21-001646.txt : 20210503
9999999995-21-001646.hdr.sgml : 20210503
20210503001508
ACCESSION NUMBER: 9999999995-21-001646
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20210430
DATE AS OF CHANGE: 20210503
EFFECTIVENESS DATE: 20210430
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akari Therapeutics Plc
CENTRAL INDEX KEY: 0001541157
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981034922
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-234219
FILM NUMBER: 21881040
BUSINESS ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: (646) 350-0702
MAIL ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Celsus Therapeutics Plc.
DATE OF NAME CHANGE: 20130621
FORMER COMPANY:
FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC
DATE OF NAME CHANGE: 20120201
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2021-04-30
0001104659-21-055819
POS AM
0001541157
Akari Therapeutics Plc
333-234219